Press release archive - GSK
Browse GSK's global press release archive for media and investors. Search by keyword or browse by year/business category. Press releases issued by our local operating companies can be viewed on our market websites.
GSK invests up to $800 million in Pennsylvania site, largest ...
Oct 24, 2024 · GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines. The new R&D and commercial facilities will double the size and capacity of the site, creating over 200 new jobs in the region.
Press releases | GSK US
New data for AREXVY, GSK’s respiratory syncytial virus vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
GSK announces independent Consumer Healthcare company is to …
Feb 22, 2022 · GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon.
GSK delivers continued strong performance and upgrades 2024 …
Jul 31, 2024 · Broad-based performance drives sales, core profit and core EPS growth: Total Q2 2024 sales £7.9 billion +13%. Vaccines sales +1%, +3% ex COVID. Shingrix £0.8 billion -4%.
GSK completes acquisition of Aiolos Bio for up to $1.4 bln
LONDON, Feb 15 (Reuters) - GSK (GSK.L) said on Thursday it had completed the acquisition of Aiolos Bio, a clinical-stage biopharmaceutical company focused on respiratory and inflammatory...
US FDA approves GSK’s AREXVY, the world’s first respiratory …
May 3, 2023 · GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved AREXVY (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. This is the first RSV vaccine for older ...
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
GSK sees strong growth as Haleon split and vaccine drive pays off
Jan 31 (Reuters) - GSK (GSK.L) beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs...